Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Cash Flow

v3.23.2
Interim Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating activities    
Net loss for the period $ (7,997) $ (7,281)
Items not affecting cash:    
Stock based compensation 519 725
Net realizable value adjustments 5,826 3,384
Amortization of mineral properties 624 624
Depreciation of capital assets 973 909
Accretion expense 247 225
Amortization of deferred loan costs 22 22
Warrant liability revaluation gain (3,061) (1,915)
Unrealized foreign exchange gain (316) (7)
Changes in non-cash working capital:    
Accounts receivable (33) (11)
Inventory (2,198) (3,384)
Prepaid expenses (150) (243)
Accounts payable and accrued liabilities 582 556
Net cash provided by used in operating activities (4,962) (6,396)
Investing activities    
Purchase of capital assets (1,186) (85)
Net Cash Provided By Used In Investing Activities (1,186) (85)
Financing activities    
Issuance of common shares and warrants for cash 46,637 3,313
Share issue costs (3,002) (83)
Proceeds from exercise of warrants and stock options 297 421
Repayment of debt (2,666) 0
Net Cash Provided By Used In Financing Activities 41,266 3,651
Effects of foreign exchange rate changes on cash 23 (32)
Increase in cash, cash equivalents, and restricted cash 35,141 (2,862)
Beginning cash, cash equivalents, and restricted cash 41,140 54,155
Ending cash, cash equivalents, and restricted cash $ 76,281 $ 51,293